News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
320 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17620)
Month
January (3398)
February (3796)
March (4054)
April (4079)
May (4309)
June (3941)
July (3248)
August (3087)
September (3751)
October (3897)
November (3988)
December (2885)
Day
1 (320)
2 (250)
3 (194)
4 (168)
5 (128)
8 (219)
9 (199)
10 (178)
11 (192)
12 (120)
15 (226)
16 (232)
17 (183)
18 (178)
19 (123)
22 (149)
23 (139)
24 (157)
25 (154)
26 (85)
29 (172)
30 (175)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
8
9
10
11
12
15
16
17
18
19
22
23
24
25
26
29
30
Drug Development
Merck & Co. Release: New Findings Show Durable Anti-Tumor Activity With KEYTRUDA (Pembrolizumab), Merck’s Anti-PD-1 Therapy, In Patients With Advanced Head And Neck Cancer, Regardless Of PD-L1 Expression Status
June 1, 2015
·
13 min read
Drug Development
ASCO15: First Study Evaluating DNA Mismatch Repair As Genetic Guide For Immunotherapy Treatment With Merck & Co.’s KEYTRUDA (Pembrolizumab) Presented At 2015 ASCO Annual Meeting And Published In The New England Journal of Medicine
June 1, 2015
·
14 min read
Business
BioAlberta Announces Mel Wong As President
June 1, 2015
·
1 min read
Drug Development
ASCO15: Threshold Pharmaceuticals, Inc. Presents Encouraging Preliminary Phase 2 Data In Multiple Myeloma At ASCO
June 1, 2015
·
10 min read
Business
Cytox Signs Research Agreement With AIBL And Partner Organisations
June 1, 2015
·
2 min read
BioCapital
CoreRx Finds Compliance X-factor With Formpipe
June 1, 2015
·
5 min read
BioMidwest
Thermo Fisher Scientific’s Next-Generation Sequencing Platform Selected For Nationwide Clinical Research Program
June 1, 2015
·
4 min read
Biotech Beach
Companiondx To Expand Pharmaceutical Services Through Combination Of Ion Torrent Oncomine Assays And Applied Biosystems Pharmacogenomics Solutions
June 1, 2015
·
3 min read
BioMidwest
Argatroban Injection Now Available From Fresenius Kabi AG
June 1, 2015
·
1 min read
Drug Development
ASCO15: Karyopharm Presents Clinical Data For Selinexor (KPT-330) In Patients With Heavily Pretreated Gynecological Cancers And Asian Patients With Advanced Malignancies At 2015 ASCO Annual Meeting
June 1, 2015
·
8 min read
Previous
11 of 32
Next
